Veterinary Medicines

Alpha Marine Vibrio, konsentrat til bad, suspensjon til torsk (Gadus morhua)

Authorised
  • Vibrio anguillarum, serotype O1, Inactivated
  • Vibrio anguillarum, serotype O2A, Inactivated
  • Vibrio anguillarum, serotype O2B, Inactivated
Download as PDF

Product identification

Medicine name:
Alpha Marine Vibrio, konsentrat til bad, suspensjon til torsk (Gadus morhua)
Active substance:
  • Vibrio anguillarum, serotype O1, Inactivated
  • Vibrio anguillarum, serotype O2A, Inactivated
  • Vibrio anguillarum, serotype O2B, Inactivated
Target species:
  • Cod
Route of administration:
  • Dipping

Product details

Active substance and strength:
  • Vibrio anguillarum, serotype O1, Inactivated
    40.00
    Relative Percentage Survival
    /
    500.00
    millilitre(s)
  • Vibrio anguillarum, serotype O2A, Inactivated
    40.00
    Relative Percentage Survival
    /
    500.00
    millilitre(s)
  • Vibrio anguillarum, serotype O2B, Inactivated
    40.00
    Relative Percentage Survival
    /
    500.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for dip suspension
Withdrawal period by route of administration:
  • Dipping
    • Cod
      • Meat and offal
        0
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI10X
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmaq AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmaq AS
Responsible authority:
  • NOMA
Authorisation number:
  • 06-3891
Date of authorisation status change:

Documents

alpha marine vibrio.PDF

Norwegian (PDF)
Published on: 21/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."